ZVRA Market Cap History



Below is a table of the ZVRA market cap history going back to 8/11/2023:

Date ZVRA Market Cap
8/11/2023176.45M
11/3/2023167.69M
3/30/2024251.87M
5/3/2024201.32M
8/12/2024358.33M

Also see: ZVRA Shares Outstanding History
and ZVRA YTD Return
ZVRA Historical Market Cap:
+102.29% CAGR
ZVRA Historical Market Cap: +102.29% CAGR

Mouse over chart for data details
8/11/202311/3/20233/30/20245/3/20248/12/2024
Zevra Therapeutics is a specialty pharmaceutical company focused on the discovery and development of treatments for central nervous system and rare disease indications that allow it to target areas with unmet needs. Co.'s prodrug product candidate pipeline is focused on the idiopathic hypersomnia (IH) and other CNS/rare diseases. Co.'s approved product, AZSTARYS®, a once-daily treatment for attention deficit hyperactivity disorder in patients, age six years and older, contains its prodrug, serdexmethylphenidate (SDX). Co.'s primary clinical development product candidate, KP1077, is based on SDX, its prodrug of d-methlyphenidate and is in development for the treatment of IH and narcolepsy. We show 5 historical shares outstanding datapoints in our ZVRA shares outstanding history coverage, used to compute ZVRA market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing ZVRA market cap history over the course of time is important for investors interested in comparing ZVRA's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of ZVRA versus a peer is one thing; comparing ZVRA market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like ZVRA can fluctuate over the course of history. With this page we aim to empower investors researching ZVRA by allowing them to research the ZVRA market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree ZVRA Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Zevra Therapeutics (ZVRA) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

ZVSA Market Cap History
ZY Market Cap History
ZYME Market Cap History
ZYNE Market Cap History
ZYXI Market Cap History
A Market Cap History
AAC Market Cap History
AADI Market Cap History
ABAX Market Cap History
ABBV Market Cap History
More Healthcare companies »

 

ZVRA Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.3%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.3%.